Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patientsYang Li, Sheng‐ce Tao, Yun-xiao Zheng et al.|Cell Reports|2021Cited by 183
Antibody dynamics to SARS‐CoV‐2 in asymptomatic COVID‐19 infectionsQing Lei, Xionglin Fan, Yang Li et al.|Allergy|2020Cited by 138
Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriersDi Yin, Yujia Cai, Yiye Zhong et al.|Nature Biomedical Engineering|2024Cited by 89
Treatment of severe COVID-19 with convalescent plasma in Bronx, NYCHyunah Yoon, Morayma Reyes Gil, Rachel Bartash et al.|JCI Insight|2021Cited by 46
Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteinsYang Li, Sheng‐ce Tao, Zhaowei Xu et al.|Cell Reports|2021Cited by 45